Brief: China Regenerative Medicine Informed That All Favour Intends To Dispose 2 Bln Shares Of Co
Jan 25 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* ANNOUNCES ACQUISITION OF SHARES BY LISTED COMPANY IN CHINA
FROM
A SUBSTANTIAL SHAREHOLDER OF COMPANY
* DISPOSAL FOR HK$360 MILLION
* INFORMED THAT ALL FAVOUR HOLDINGS INTENDED TO DISPOSE OF 2
BILLION SHARES OF CO TO BLB INTERNATIONAL
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7Cwd73
Further company coverage: 8158.HK
(bangalore.newsroom@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital